HPRA Drug Safety Newsletter Edition 112
Download:
hpra-drug-safety-newsletter-edition-112.pdf
635 KB
The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Fluoroquinolone antibiotics: Reminder about restrictions of use and risk of rare but serious long lasting adverse reactions
- Hydroxychloroquine: Risk of drug-induced liver injury
- Tramadol-containing medicines: New warnings and precautions for use regarding sleep related breathing disorders, adrenal insufficiency and serotonin syndrome
- Product information updates recommended by the EMA’s Pharmacovigilance Risk assessment Committee (PRAC)
Product information updates recommended by the EMA’s Pharmacovigilance Risk assessment Committee (PRAC)Product information updates recommended by the EMA’s Pharmacovigilance Risk assessment Committee (PRAC)Tramadol-containing medicines: New warnings and precautions for use regarding sleep related breathing disorders, adrenal insufficiency and serotonin syndrome
« Back